Clearbridge Investments, LLC Aerie Pharmaceuticals Inc Transaction History

Clearbridge Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.02 - $13.33 $6.12 Million - $11.6 Million	-871,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $934,760 - $1.37 Million	-82,576 Reduced 8.66%	871,200 $9.93 Million
Q2 2021 Aug 13, 2021	SELL	$15.16 - $18.97 $62,489 - $78,194	-4,122 Reduced 0.43%	953,776 $15.3 Million
Q1 2021 May 13, 2021	BUY	$13.12 - $20.9 $4.14 Million - $6.6 Million	315,655 Added 49.15%	957,898 $17.1 Million
Q4 2020 Feb 10, 2021	BUY	$9.12 - $14.49 $82,536 - $131,134	9,050 Added 1.43%	642,243 $8.68 Million
Q3 2020 Nov 12, 2020	SELL	$10.46 - $14.46 $31,191 - $43,119	-2,982 Reduced 0.47%	633,193 $7.45 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $329,760 - $443,252	27,480 Added 4.51%	636,175 $9.39 Million
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $48,023 - $103,509	-4,056 Reduced 0.66%	608,695 $8.22 Million
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $3.64 Million - $5.16 Million	205,421 Added 50.43%	612,751 $14.6 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $7.5 Million - $11.4 Million	407,330 New	407,330 $7.83 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.